Cargando…
Humoral immune response to COVID-19 vaccines in people with secondary progressive multiple sclerosis treated with siponimod
The aim of this study is to determine a development of humoral response after COVID-19 vaccination in persons with secondary progressive multiple sclerosis (pwSPMS) on siponimod, compared to healthy controls (HC).Methods: In 13 pwSPMS taking siponimod and 11 HC, testing for SARS-CoV2 antibodies was...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier B.V.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8629510/ https://www.ncbi.nlm.nih.gov/pubmed/34920248 http://dx.doi.org/10.1016/j.msard.2021.103435 |